Cargando…

Cyclophosphamide vs salvage chemotherapy plus G-CSF as chemo-mobilization in Asian patients undergoing autologous hematopoietic stem cell transplant

Detalles Bibliográficos
Autores principales: Issaragrisil, S, Cheng-Hwai, T, Bunworasate, U, Su-Peng, Y, Hung, L Y, Tee, G Y, Wahid, S F A, Chin, N S, Puavilai, T, Gin, G G, Piu, K L, Wen-Li, H, Tsai-Yun, C, Numbenjapon, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292601/
https://www.ncbi.nlm.nih.gov/pubmed/27841857
http://dx.doi.org/10.1038/bmt.2016.245
_version_ 1782504953414156288
author Issaragrisil, S
Cheng-Hwai, T
Bunworasate, U
Su-Peng, Y
Hung, L Y
Tee, G Y
Wahid, S F A
Chin, N S
Puavilai, T
Gin, G G
Piu, K L
Wen-Li, H
Tsai-Yun, C
Numbenjapon, T
author_facet Issaragrisil, S
Cheng-Hwai, T
Bunworasate, U
Su-Peng, Y
Hung, L Y
Tee, G Y
Wahid, S F A
Chin, N S
Puavilai, T
Gin, G G
Piu, K L
Wen-Li, H
Tsai-Yun, C
Numbenjapon, T
author_sort Issaragrisil, S
collection PubMed
description
format Online
Article
Text
id pubmed-5292601
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-52926012017-02-10 Cyclophosphamide vs salvage chemotherapy plus G-CSF as chemo-mobilization in Asian patients undergoing autologous hematopoietic stem cell transplant Issaragrisil, S Cheng-Hwai, T Bunworasate, U Su-Peng, Y Hung, L Y Tee, G Y Wahid, S F A Chin, N S Puavilai, T Gin, G G Piu, K L Wen-Li, H Tsai-Yun, C Numbenjapon, T Bone Marrow Transplant Letter to the Editor Nature Publishing Group 2017-02 2016-11-14 /pmc/articles/PMC5292601/ /pubmed/27841857 http://dx.doi.org/10.1038/bmt.2016.245 Text en Copyright © 2017 The Author(s) http://creativecommons.org/licenses/by-nc-sa/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
spellingShingle Letter to the Editor
Issaragrisil, S
Cheng-Hwai, T
Bunworasate, U
Su-Peng, Y
Hung, L Y
Tee, G Y
Wahid, S F A
Chin, N S
Puavilai, T
Gin, G G
Piu, K L
Wen-Li, H
Tsai-Yun, C
Numbenjapon, T
Cyclophosphamide vs salvage chemotherapy plus G-CSF as chemo-mobilization in Asian patients undergoing autologous hematopoietic stem cell transplant
title Cyclophosphamide vs salvage chemotherapy plus G-CSF as chemo-mobilization in Asian patients undergoing autologous hematopoietic stem cell transplant
title_full Cyclophosphamide vs salvage chemotherapy plus G-CSF as chemo-mobilization in Asian patients undergoing autologous hematopoietic stem cell transplant
title_fullStr Cyclophosphamide vs salvage chemotherapy plus G-CSF as chemo-mobilization in Asian patients undergoing autologous hematopoietic stem cell transplant
title_full_unstemmed Cyclophosphamide vs salvage chemotherapy plus G-CSF as chemo-mobilization in Asian patients undergoing autologous hematopoietic stem cell transplant
title_short Cyclophosphamide vs salvage chemotherapy plus G-CSF as chemo-mobilization in Asian patients undergoing autologous hematopoietic stem cell transplant
title_sort cyclophosphamide vs salvage chemotherapy plus g-csf as chemo-mobilization in asian patients undergoing autologous hematopoietic stem cell transplant
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292601/
https://www.ncbi.nlm.nih.gov/pubmed/27841857
http://dx.doi.org/10.1038/bmt.2016.245
work_keys_str_mv AT issaragrisils cyclophosphamidevssalvagechemotherapyplusgcsfaschemomobilizationinasianpatientsundergoingautologoushematopoieticstemcelltransplant
AT chenghwait cyclophosphamidevssalvagechemotherapyplusgcsfaschemomobilizationinasianpatientsundergoingautologoushematopoieticstemcelltransplant
AT bunworasateu cyclophosphamidevssalvagechemotherapyplusgcsfaschemomobilizationinasianpatientsundergoingautologoushematopoieticstemcelltransplant
AT supengy cyclophosphamidevssalvagechemotherapyplusgcsfaschemomobilizationinasianpatientsundergoingautologoushematopoieticstemcelltransplant
AT hungly cyclophosphamidevssalvagechemotherapyplusgcsfaschemomobilizationinasianpatientsundergoingautologoushematopoieticstemcelltransplant
AT teegy cyclophosphamidevssalvagechemotherapyplusgcsfaschemomobilizationinasianpatientsundergoingautologoushematopoieticstemcelltransplant
AT wahidsfa cyclophosphamidevssalvagechemotherapyplusgcsfaschemomobilizationinasianpatientsundergoingautologoushematopoieticstemcelltransplant
AT chinns cyclophosphamidevssalvagechemotherapyplusgcsfaschemomobilizationinasianpatientsundergoingautologoushematopoieticstemcelltransplant
AT puavilait cyclophosphamidevssalvagechemotherapyplusgcsfaschemomobilizationinasianpatientsundergoingautologoushematopoieticstemcelltransplant
AT gingg cyclophosphamidevssalvagechemotherapyplusgcsfaschemomobilizationinasianpatientsundergoingautologoushematopoieticstemcelltransplant
AT piukl cyclophosphamidevssalvagechemotherapyplusgcsfaschemomobilizationinasianpatientsundergoingautologoushematopoieticstemcelltransplant
AT wenlih cyclophosphamidevssalvagechemotherapyplusgcsfaschemomobilizationinasianpatientsundergoingautologoushematopoieticstemcelltransplant
AT tsaiyunc cyclophosphamidevssalvagechemotherapyplusgcsfaschemomobilizationinasianpatientsundergoingautologoushematopoieticstemcelltransplant
AT numbenjapont cyclophosphamidevssalvagechemotherapyplusgcsfaschemomobilizationinasianpatientsundergoingautologoushematopoieticstemcelltransplant